Three Year Interval for Cervical Cancer Screening

Regular screening for cervical cancer is an important preventative care step that drastically reduces rates of advanced cervical cancer and allows physicians to detect cancer at early stages. While the preferred frequency of cervical cancer screenings may vary between healthcare providers, a new study from New Mexico indicates that screening every 3 years may be […]

Read More

Reduced Survival with Higher Radiation Dose for Non-Hodgkin Lymphoma

Prior to hematopoietic stem cell transplant (HSCT), patients with non-Hodgkin lymphoma (NHL) typically undergo total body irradiation and chemotherapy as part of a conditioning regimen. In order to reduce the risk of relapse following HSCT, some patients with higher risk disease may receive higher doses of radiation. However, according to a study presented recently at […]

Read More

Watch-And-Wait An Effective Treatment Strategy in Rectal Cancer

For patients with early stage rectal cancer who achieve complete response following chemoradiotherapy, next steps for treatment are not always clear. While some believe patients should undergo total mesorectal excision, others prefer a more conservative strategy of active surveillance, or “watch-and-wait.” Unfortunately, there are limited data on the long-term impact of watch-and-wait on patient outcomes. […]

Read More

Therapy-Associated Polyposis in Younger Patients with Cancer

In recent years, therapy-associated polyposis (TAP) has emerged as a potential side effect of cancer therapy in children and young adults, potentially associated with an increased risk of gastrointestinal (GI) cancer later in life. However, only 8 cases of TAP in cancer survivors have been reported and the link between cancer treatment and polyposis is […]

Read More

Cancer “Victory Bell” May Cause Treatment-Related Distress

Ringing the “victory bell” to signal the end of cancer treatment is considered a rite of passage for survivors, associated with successful treatment. However, this ceremony is controversial, with some patient advocates suggesting it may cause feelings of anger or depression in patients with metastatic disease who require chronic treatment. Now the first-ever prospective controlled […]

Read More

Improving Outcomes for Bone Marrow Transplant Recipients

Bone marrow transplant is a common treatment option for many patients with hematologic malignancies, but these transplants have historically been associated with significant morbidity and mortality. However, a retrospective analysis published in the Annals of Internal Medicine shows that outcomes for patients who receive bone marrow transplants have improved substantially in recent decades. The analysis […]

Read More

Atezolizumab and Bevacizumab Improve Quality of Life in HCC

While patients with unresectable hepatocellular carcinoma (HCC) have historically received first-line treatment with sorafenib, results from the IMbrave150 suggest that the combination of the PD-L1 inhibitor atezolizumab with the angiogenesis inhibitor bevacizumab may be a more effective treatment option. Initial results from this randomized, phase III trial (N = 501) showed a significant overall survival […]

Read More